Austin, TX (June 13, 2017) BioPact’s nanodelivery technology produced in vivo evidence that the carbon nanotube-based drug delivery system, Medical-Grade MOLECULAR REBAR® (MGMR®), successfully treated two forms of cancer while reducing the side effects of the API in this study, Doxorubicin. The studies were conducted at Charles River Laboratories and utilized two orthotopic cancer […]